CGM and DFU Healing Post-discharge

NARecruitingINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

February 20, 2024

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions
Diabetic FootDiabetes Type 2 With Diabetic Ulcer of Toe, Skin Breakdown
Interventions
DEVICE

Real Time Continuous Glucose Monitoring (rt-CGM)

Participants randomized to rt-CGM will have CGM placed before hospital discharge. They will also receive teaching from the research team on the proper use of their CGM sensor and reader. The study team will provide CGM devices, but subjects may use their glucometer for FBG testing as needed for CGM calibration.

OTHER

Fingerstick blood glucose (FBG) monitoring

Participants will use their own glucometer for FBG testing as advised by their treating provider (usually primary care or diabetes doctor).

BEHAVIORAL

Diabetes Education

Participants will receive standard-of-care diabetes education with a certified diabetes educator (CDE) prior to discharge (with the approval of the treating inpatient team).

Trial Locations (2)

30033

ACTIVE_NOT_RECRUITING

Emory Decatur Hospital, Decatur

30303

RECRUITING

Grady Health System, Atlanta

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Emory University

OTHER